Browsing by Author Viale, Giuseppe

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 27  next >
Issue DateTitleAuthor(s)Citation
2016Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT TrialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Pinotti, Graziella; Price, Karen N; Regan, Meredith; Tondini, Carlo; Viale, Giuseppe; Walley, Barbara; School of Public Health: Public HealthAbsolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2221-2230
2016Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trialBoyle, Frances; Amour, Alison; Baselga, Jose; De Azambuja, Evandro; Dueck, Amylou C.; et al, .; Goldhirsch, Aron; Holmes, Eileen; Piccart-Gebhart, Martine; Pritchard, Kathleen; Viale, Giuseppe; Zujewski, Jo Anne; Northern Clinical School: MedicineAdjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial, Journal of Clinical Oncology, vol.34, 10, 2016,pp 1034-1042
2008Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trialCoates, Alan; Altermatt, Hans J; Braye, Stephen; Castiglione-Gertsch, Monica; Del Curto, Barbara; Dell'Orto, Patrizia; Gelber, Richard D. (Prof); Goldhirsch, A; Gusterson, Barry; Henriksen, Katrine L; Lacroix-Triki, Magali; Lykkesfeldt, Anne E; Mastropasqua, Mauro G.; Mery, Eliane; Price, K. N.; Rasmussen, Brigitte B; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthAdjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial, The Lancet, vol.9, N/A, 2008,pp 23-28
2015Adjuvant ovarian suppression in premenopausal breast cancerCoates, Alan; Bellet, Meritxell; Bonnefoi, Herve; Buchholz, Stefan; Burstein, Harold; Ciruelos, Eva; Climent, Miguel; Coleman, Richard; Colleoni, Marco; Da Prada, Gian; Davidson, Nancy; Fleming, Gini; Francis, Prudence; Gelber, Richard D. (Prof); Geyer, Charles; Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Ingle, J.; Kerbrat, Pierre; Lang, Istvan; Maibach, Rudolph; Martino, Silvana; Price, K. N; Rabaglio-Poretti, Manuela; Regan, Meredith; Ruepp, Barbara; Viale, Giuseppe; Walley, Barbara; Winer, EP; School of Public Health: Public HealthAdjuvant ovarian suppression in premenopausal breast cancer, The New England Journal of Medicine, vol.372, 5, 2015,pp 436-446
2010Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et al, various; Giobbie-Hurder, Anita; Gusterson,, B; Maiorano, Eugenio; Mallon, Elizabeth; Mastropasqua, Mauro G.; Sonzogni, A; Viale, Giuseppe; School of Public Health: Public HealthAdverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer., Annals of Oncology, vol.21, 2,pp 245-254
2010Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancersCoates, Alan; Accortanzo, Valeria; Allin, Elena; Arisio, Riccardo; Bussolati, Gianni; Castellano, Isabella; Chiusa, Luigi; Donadio, Michela; Durando, Antonio; Vandone, Anna Marie; Viale, Giuseppe; School of Public Health: Public HealthAndrogen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers, Breast Cancer Research and Treatment, vol.124, 3,pp 607-617
2013Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trialCoates, Alan; Baratella, Paola; Chifu, Camelia; Cole, Bernard; et al, Various; Galimberti, Viviana; Intra, Mattia; Luini, Alberto; Sargenti, Manuela; Veronesi, Paolo; Viale, Giuseppe; Zurrida, Stefano; School of Public Health: Public HealthAxillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial, Lancet Oncology, vol.14, 4, 2013,pp 297-305
2008Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study GroupCoates, Alan; Braye, Stephen; Brown, Robert; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Gusterson, Barry A.; Kovacs, Aniko; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Perin, Tiziana; Pillay, Komala; Price, Karen N.; Regan, Meredith M.; Rusca, Tiziana; Viale, Giuseppe; School of Public Health: Public HealthChemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study Group, Journal of Clinical Oncology, vol.26, 9, 2008,pp 1404-1410
2010Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast CancerCoates, Alan; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Gusterson, Barry; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen N.; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthClassical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer, Journal of Clinical Oncology, vol.28, 18, 2010,pp 2966-2973
2003Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node statusCoates, Alan; Byrne, Michael J.; Castiglione-Gertsch, Monica; Collins, John; Cortes-Funes, Hernan; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Lindtner, Jurii; Litman, H; Maffini, Fausto; Martinez-Tello, Francisco J.; Masullo, Michele; Price, Karen; Simoncini, Edda; Spataro, Vito J.; Viale, Giuseppe; School of Public Health: Public HealthDecreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status, Cancer, vol.97,(7),2003,pp 1591-1600
2011Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX.Coates, Alan; Aebi, S; Braun, D; Castiglione-Gertsch, M; Crivellari, Diana; Gelber, Richard; Goldhirsch, A; Gusterson, B. A.; Karlsson, P; Lindtner, Jurii; Price, K. N.; Rabaglio, Manuela; Regan, Meredith M.; Simoncini, Edda; Snyder, Raymond; Sun, Z; Viale, Giuseppe; School of Public Health: Public HealthDifferential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX., Annals of Oncology, vol.22, 9, 2011,pp 1981-1987
2008Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical TrialsCoates, Alan; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron; Gusterson, Barry A.; Holmberg, Stig B.; Lindtner, Jurii; Mallon, Elizabeth; Murray, E.; Pestalozzi, B. C.; Price, Karen N.; Snyder, Raymond; Thurlimann, Beat; Viale, Giuseppe; Zahrieh, David; School of Public Health: Public HealthDistinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials, Journal of Clinical Oncology, vol.26, 18, 2008,pp 3006-3014
2012HER2 testing in gastric cancer: A practical approachBilous, Michael; Hanna, Wedad; Hofmann, Manfred; Osamura, Robert Y.; Penault-Llorca, Frederique; Ruschoff, J; van de Vijver, Marc; Viale, Giuseppe; Western Clinical School: Medicine (Westmead)HER2 testing in gastric cancer: A practical approach, Modern Pathology, vol.25, 5, 2012,pp 637-650
2016Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trialCoates, Alan; Aristarco, Valentina; et al, Various; Gray, Kathryn P; Johansson, Harriet; Macis, Debora; Pagani, Olivia; Puccio, Antonella; Regan, Meredith; Roux, Susanne; Viale, Giuseppe; School of Public Health: Public HealthImpact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial, Breast Cancer Research, vol.18, 1, 2016,pp 1-12
2008Lack of prognostic significance of ‘‘classic’’ lobular breast carcinoma: a matched, single institution seriesCoates, Alan; Colleoni, Marco; Galimberti, Viviana; Goldhirsch, Aron; Luini, Alberto; Maiorano, Eugenio; Maisonneuve, Patrick; Orvieto, Enrico; Rotmensz, N; Viale, Giuseppe; School of Public Health: Public HealthLack of prognostic significance of ‘‘classic’’ lobular breast carcinoma: a matched, single institution series, Breast Cancer Research and Treatment, vol.117,(1),2008,pp 211-214
2015Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trialCoates, Alan; Bibeau, Frederic; Ejlertsen, Bent; et al, Various; Giobbie-Hurder, Anita; Gusterson, Barry A; Lelkaitis, Gierdrius; MacGrogan, G.; Mallon, Elizabeth; Munzone, Elisabetta; Thurlimann, B.; Viale, Giuseppe; School of Public Health: Public HealthOutcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial, Annals of Oncology, vol.26, 12, 2015,pp 2442-2449
2008p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Gianni, Lorenzo; Goldhirsch, Aron; Gusterson, Barry; Maffini, Fausto; Mastropasqua, M; Monti, F; Panzini, Ilaria; Price, Karen; Ravaioli, A; Regan, Meredith M.; Spataro, Vito J.; Viale, Giuseppe; School of Public Health: Public Healthp27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer., Annals of Oncology, vol.19, 4, 2008,pp 660-668
2013Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node-Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IXCoates, Alan; Cardoso, Fatima; Castiglione-Gertsch, Monica; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, A; Metzger-Filho, Otto; Price, Karen N; Snyder, Raymond; Viale, Giuseppe; Zhuoxin, Sun; School of Public Health: Public HealthPatterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node-Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX, Journal of Clinical Oncology, vol.31, 25, 2013,pp 3083-3091
2008Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancerCoates, Alan; Colleoni, Marco; et al, various; Golouh, Rastko; Maffini, Fausto; Maiorano, Eugenio; Mastropasqua, Mauro G.; Perin, Tiziana; Price, K N; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthPredictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer, Journal of the National Cancer Institute, vol.100,(3),2008,pp 207-212
2012Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsCoates, Alan; Gelber, Richard D. (Prof); Gelber, S.; Goldhirsch, Aron; Huober, J; Ohlschlegel, Christian; Price, K. N; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthPrognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials, Annals of Oncology, vol.23, 11, 2012,pp 2843-2851